Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2002 1
2004 2
2005 2
2006 3
2007 1
2008 2
2010 2
2011 5
2012 5
2013 3
2014 7
2015 4
2016 4
2017 6
2018 6
2019 8
2020 11
2021 10
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Cancer Vaccines.
DeMaria PJ, Bilusic M. DeMaria PJ, et al. Among authors: bilusic m. Hematol Oncol Clin North Am. 2019 Apr;33(2):199-214. doi: 10.1016/j.hoc.2018.12.001. Epub 2019 Jan 28. Hematol Oncol Clin North Am. 2019. PMID: 30832995 Review.
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V, Stenzl A, Csöszi T, Filipovic Z, Goncalves F, Prokhorov A, Cheung E, Hussain A, Sousa N, Bahl A, Hussain S, Fricke H, Kadlecova P, Scheiner T, Korolkiewicz RP, Bartunkova J, Spisek R; VIABLE Investigators. Vogelzang NJ, et al. JAMA Oncol. 2022 Apr 1;8(4):546-552. doi: 10.1001/jamaoncol.2021.7298. JAMA Oncol. 2022. PMID: 35142815 Free PMC article. Clinical Trial.
Immunotherapy of Prostate Cancer: Facts and Hopes.
Bilusic M, Madan RA, Gulley JL. Bilusic M, et al. Clin Cancer Res. 2017 Nov 15;23(22):6764-6770. doi: 10.1158/1078-0432.CCR-17-0019. Epub 2017 Jun 29. Clin Cancer Res. 2017. PMID: 28663235 Free PMC article. Review.
Neoadjuvant Immunotherapy: An Evolving Paradigm Shift?
Bilusic M, Gulley JL. Bilusic M, et al. J Natl Cancer Inst. 2021 Jul 1;113(7):799-800. doi: 10.1093/jnci/djaa217. J Natl Cancer Inst. 2021. PMID: 33432346 Free PMC article. No abstract available.
Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer.
Rich BJ, Montoya C, Jin WH, Spieler BO, Mahal BA, Delgadillo R, Bilusic M, Abramowitz MC, Pollack A, Dal Pra A. Rich BJ, et al. Among authors: bilusic m. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):718-724. doi: 10.1016/j.ijrobp.2022.05.040. Epub 2022 Jun 4. Int J Radiat Oncol Biol Phys. 2022. PMID: 35671868 No abstract available.
Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review.
Jung K, Ghatalia P, Litwin S, Horwitz EM, Uzzo RG, Greenberg RE, Viterbo R, Geynisman DM, Kutikov A, Plimack ER, Smaldone MC, Wong YN, Bilusic M. Jung K, et al. Among authors: bilusic m. Clin Genitourin Cancer. 2017 Jun;15(3):e337-e343. doi: 10.1016/j.clgc.2016.09.005. Epub 2016 Sep 30. Clin Genitourin Cancer. 2017. PMID: 27991416 Free PMC article. Review.
84 results